Navellier & Associates Inc Baxter International Inc Transaction History

Navellier & Associates Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Jan 15, 2019	SELL	$61.45 - $77.8 $231,359 - $292,917	-3,765 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$70.71 - $77.75 $141,420 - $155,500	-2,000 Reduced 34.69%	3,765 $290,000
Q2 2018 Aug 06, 2018	SELL	$63.43 - $75.41 $4.87 Million - $5.79 Million	-76,790 Reduced 93.02%	5,765 $426,000
Q1 2018 May 21, 2018	BUY	$62.56 - $72.26 $521,312 - $602,142	8,333 Added 11.23%	82,555 $5.37 Million
Q4 2017 Feb 12, 2018	SELL	$61.45 - $66.05 $222,387 - $239,034	-3,619 Reduced 4.65%	74,222 $4.8 Million
Q3 2017 Nov 14, 2017	SELL	$59.5 - $64.61 $731,493 - $794,315	-12,294 Reduced 13.64%	77,841 $4.89 Million
Q2 2017 Aug 24, 2017	BUY	N/A	90,135	90,135 $5.46 Million

1,007

451M

2.79M

2.44M

Ticker BAX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 504,120,992
Market Cap $16.6B
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...

Get notified when there are updates to the investment portfolio of Navellier & Associates Inc, based on Form 13F filings with the SEC.

Stay updated on Navellier & Associates Inc with notifications on news.